Chagas disease (CD) — a tropical parasitic disease caused by the protozoan Trypanosoma cruzi — is a major health problem in Latin America. The immune response against the parasite is responsible for chronic CD lesions. Currently, there are no reports of an association between CD and membranous nephropathy (MN). The detection of the phospholipase A2 receptor (PLA2R) as a target antigen in idiopathic MN can improve the differential diagnosis of primary and secondary forms of MN. The authors report the case of a male patient with positive serology for CD who presented sudden death and underwent autopsy. Histological sections of the heart showed multifocal inflammatory infiltrate composed mainly of mononuclear cells, leading to myocardiocytes necrosis and interstitial fibrosis. The kidneys showed a MN with positive expression for PLA2R. As far as we know, this is the first report of a case of primary MN in a patient with CD, with severe chronic cardiomyopathy and heart failure.
FabbroDL, OliveraV, BizaiML, et al. Humoral immune response against P2β from Trypanosoma cruzi in persons with chronic Chagas disease: its relationship with treatment against parasites and myocardial damage. Am J Trop Med Hyg. 2011;84(4):575-80. [https://doi.org/10.4269/ajtmh.2011.10-0261]. [PMID:21460013]
AndradeZA, de QueirozAC. Lesões renais na esquistossomose hepatesplênica. Rev Inst Med Trop Sao Paulo. 1968;10(1):36-40. [PMID:5683035]
BeckLHJr, BonegioRG, LambeauG, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11-21. [https://doi.org/10.1056/NEJMoa0810457]. [PMID:19571279]
DebiecH, MartinL, JouanneauC, et al. Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy. Am J Transplant. 2011;11(10):2144-52. [https://doi.org/10.1111/j.1600-6143.2011.03643.x]. [PMID:21827616]
HoxhaE, HarendzaS, ZahnerG, et al. An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant. 2011;26(8):2526-32. [https://doi.org/10.1093/ndt/gfr247]. [PMID:21633097]
HofstraJM, BeckLHJr, BeckDM, WetzelsJF, SalantDJ. Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2011;6(6):1286-91. [https://doi.org/10.2215/CJN.07210810]. [PMID:21474589]
HoxhaE, KneißlerU, StegeG, et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int. 2012;82(7):797-804. [https://doi.org/10.1038/ki.2012.209]. [PMID:22673885]
Segarra-MedranoA, Jatem-EscalanteE, Carnicer-CáceresC, et al. Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus. Nefrologia. 2014;34(4):491-7. [PMID:25036063]
ArdalanM, GhafariA, HamzaviF, et al. Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: A report from Iranian population. J Nephropathol. 2013;2(4):241-8. [PMID:24475456]
BehnertA, SchifferM, Müller-DeileJ, BeckLHJr, MahlerM, FritzlerMJ. Antiphospholipase A₂ receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy. J Immunol Res. 2014;2014(143274):1-5. [https://doi.org/10.1155/2014/143274]. [PMID:24812637]
Segarra-MedranoA, Jatem-EscalanteE, Quiles-PérezMT, et al. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. Nefrologia. 2014b;34(3):353-9. [PMID:24798555]
NoelLH, ZanettiM, DrozD, BarbanelC. Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients. Am J Med. 1979;66(1):82-90. [https://doi.org/10.1016/0002-9343(79)90486-8]. [PMID:420255]
DonadioJVJr, TorresVE, VelosaJA, et al. Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int. 1988;33(3):708-15. [https://doi.org/10.1038/ki.1988.56]. [PMID:3367560]
VieroR, SoaresV. Nefropatia membranosa: estudo clínico-morfológico de 28 pacientes. J Bras Nefrol. 2002;24(4):161-7.
PolancoN, GutiérrezE, RiveraF, et al. Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment. Nephrol Dial Transplant. 2012;27(1):231-4. [https://doi.org/10.1093/ndt/gfr285]. [PMID:21624942]
SvobodovaB, HonsovaE, RoncoP, TesarV, DebiecH. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrol Dial Transplant. 2013;28(7):1839-44. [https://doi.org/10.1093/ndt/gfs439]. [PMID:23223223]
RowPG, CameronJS, TurnerDR, et al. Membranous nephropathy. Long-term follow-up and association with neoplasia. Q J Med. 1975;44(174):207-39. [PMID:1178811]
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email